A detailed history of Godsey & Gibb Associates transactions in Merck & Co., Inc. stock. As of the latest transaction made, Godsey & Gibb Associates holds 176,433 shares of MRK stock, worth $17.3 Million. This represents 1.92% of its overall portfolio holdings.

Number of Shares
176,433
Previous 173,235 1.85%
Holding current value
$17.3 Million
Previous $21.4 Million 6.58%
% of portfolio
1.92%
Previous 2.22%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$111.15 - $128.97 $355,457 - $412,446
3,198 Added 1.85%
176,433 $20 Million
Q2 2024

Jul 23, 2024

SELL
$123.8 - $132.96 $2.37 Million - $2.55 Million
-19,144 Reduced 9.95%
173,235 $21.4 Million
Q1 2024

Apr 23, 2024

SELL
$113.24 - $131.95 $113,579 - $132,345
-1,003 Reduced 0.52%
192,379 $25.4 Million
Q4 2023

Jan 16, 2024

BUY
$100.18 - $109.02 $205,268 - $223,381
2,049 Added 1.07%
193,382 $21.1 Million
Q3 2023

Oct 25, 2023

SELL
$102.95 - $114.33 $247,697 - $275,077
-2,406 Reduced 1.24%
191,333 $19.7 Million
Q2 2023

Jul 25, 2023

SELL
$108.61 - $118.38 $1.32 Million - $1.43 Million
-12,118 Reduced 5.89%
193,739 $22.4 Million
Q1 2023

Apr 18, 2023

SELL
$102.94 - $114.86 $838,858 - $935,994
-8,149 Reduced 3.81%
205,857 $21.9 Million
Q4 2022

Jan 18, 2023

BUY
$87.44 - $112.11 $18.7 Million - $24 Million
214,006 New
214,006 $0
Q2 2022

Jul 25, 2022

SELL
$83.49 - $94.64 $19.1 Million - $21.7 Million
-229,236 Closed
0 $0
Q1 2022

Apr 28, 2022

BUY
$73.51 - $82.4 $16.9 Million - $18.9 Million
229,236 New
229,236 $18.8 Million
Q2 2021

Aug 05, 2021

SELL
$70.31 - $77.77 $14.8 Million - $16.4 Million
-210,622 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$68.86 - $81.11 $956,740 - $1.13 Million
13,894 Added 7.06%
210,622 $16.2 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $689,853 - $765,595
9,612 Added 5.14%
196,728 $16.1 Million
Q3 2020

Nov 10, 2020

BUY
$73.18 - $82.95 $43,029 - $48,774
588 Added 0.32%
187,116 $15.5 Million
Q2 2020

Aug 12, 2020

SELL
$70.42 - $80.13 $4,718 - $5,368
-67 Reduced 0.04%
186,528 $14.4 Million
Q1 2020

May 11, 2020

SELL
$63.36 - $87.82 $104,860 - $145,342
-1,655 Reduced 0.88%
186,595 $14.4 Million
Q4 2019

Feb 06, 2020

BUY
$77.58 - $87.54 $221,413 - $249,839
2,854 Added 1.54%
188,250 $17.1 Million
Q3 2019

Nov 13, 2019

SELL
$76.08 - $82.93 $1.56 Million - $1.7 Million
-20,460 Reduced 9.94%
185,396 $15.6 Million
Q2 2019

Aug 07, 2019

SELL
$69.84 - $81.59 $38,342 - $44,792
-549 Reduced 0.27%
205,856 $17.3 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $111,884 - $127,610
-1,608 Reduced 0.77%
206,405 $17.2 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $53,170 - $61,703
815 Added 0.39%
208,013 $15.9 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $498,960 - $586,748
8,649 Added 4.36%
207,198 $14.7 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $1.06 Million - $1.25 Million
-20,868 Reduced 9.51%
198,549 $12.1 Million
Q1 2018

May 11, 2018

BUY
$50.96 - $59.23 $601,328 - $698,914
11,800 Added 5.68%
219,417 $12 Million
Q4 2017

Jan 23, 2018

SELL
$51.62 - $61.64 $45,322 - $54,119
-878 Reduced 0.42%
207,617 $11.7 Million
Q3 2017

Nov 03, 2017

SELL
$58.67 - $63.13 $862,859 - $928,452
-14,707 Reduced 6.59%
208,495 $13.4 Million
Q2 2017

Aug 11, 2017

BUY
N/A
223,202
223,202 $14.3 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Godsey & Gibb Associates Portfolio

Follow Godsey & Gibb Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Godsey & Gibb Associates, based on Form 13F filings with the SEC.

News

Stay updated on Godsey & Gibb Associates with notifications on news.